Campbell Soup's stock up as it beats Wall Street profit and revenue estimates 
 

Iconic soup maker introduces a cautious tone to its full-year sales guidance.


 
GE Spinoff Vernova Gives 2025 Guidance. What It Means for the Stock. 
 

Power-generation firm GE Vernova provided some guidance to investors and analysts. Jefferies analyst Sheila Kahyaoglu reckons each share is worth about $112.


 
Foot Locker Stock Is Tumbling. Don't Blame Earnings. 
 

Athletic-footwear retailer Foot Locker posted a strong fourth quarter, but said its plan for sustainable growth was now delayed two years.


 
Abercrombie & Fitch Stock Is Slipping After Strong Earnings 
 

Apparel retailer Abercrombie reported a strong fourth quarter, and provided upbeat guidance. Shares are lower after a massive run-up in recent months.


 
Brown-Forman's stock dips after Jack Daniel's parent's sales fall short of estimates 
 

Brown-Forman Corp. 's stock fell 4.6% early Wednesday, after the parent of Jack Daniel's whiskey's fiscal third-quarter sales fell short of estimates, overshadowing a profit beat.


 
Microsoft Engineer Warns AI Tool Generates Harmful Images, Needs Better Safeguards 
 

In letters to Microsoft and the FTC, Shane Jones urged government to work with tech companies to make AI safer.


 
You Can Now Buy Shares in Music by Beyoncé or Taylor Swift 
 

The startup JKBX is offering securities backed by the royalty streams from songs recorded by popular artists.


 
Moderna Looks to Pare R&D Spending Even as It Pivots From Covid Vaccines 
 

The biotech company is advancing new offerings in part to offset revenue declines while also trying to bring costs down.


 
Asia's E-Commerce Battlefield Is Expanding Fast 
 

E-commerce battles in Asia have produced some household names such as Temu. Korea's contender Coupang could be next up.


 
Oprah's Breakup With WeightWatchers Shows Turnaround Won't be Easy 
 

The company is seeking to turn its business around by adding subscribers to its new clinical business, which prescribes medications such as Ozempic and Zepbound.


(END) Dow Jones Newswires

03-06-24 1115ET